Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 26, 2017

DrugPatentWatch Database Preview

CLINDAMYCIN HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Clindamycin Hydrochloride, and when can generic versions of Clindamycin Hydrochloride launch?

Clindamycin Hydrochloride is a drug marketed by Zydus Pharms Usa, Mylan Pharms Inc, Teva, G And W Labs Inc, Aurobindo Pharma, Lannett, Sun Pharm Inds Ltd, Watson Labs, and Corepharma. and is included in eleven NDAs.

The generic ingredient in CLINDAMYCIN HYDROCHLORIDE is clindamycin hydrochloride. There are fifty-two drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the clindamycin hydrochloride profile page.

Summary for Tradename: CLINDAMYCIN HYDROCHLORIDE

Patents:0
Applicants:9
NDAs:11
Suppliers / Packagers: see list39
Bulk Api Vendors: see list73
Clinical Trials: see list1,039
Patent Applications: see list991
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CLINDAMYCIN HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: CLINDAMYCIN HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms Usa
CLINDAMYCIN HYDROCHLORIDE
clindamycin hydrochloride
CAPSULE;ORAL065217-001Jan 31, 2005ABRXNoNo► Subscribe► Subscribe
Watson Labs
CLINDAMYCIN HYDROCHLORIDE
clindamycin hydrochloride
CAPSULE;ORAL063083-001Jul 31, 1991ABRXNoNo► Subscribe► Subscribe
Teva
CLINDAMYCIN HYDROCHLORIDE
clindamycin hydrochloride
CAPSULE;ORAL063027-001Sep 20, 1989DISCNNoNo► Subscribe► Subscribe
Mylan Pharms Inc
CLINDAMYCIN HYDROCHLORIDE
clindamycin hydrochloride
CAPSULE;ORAL091225-001May 31, 2011ABRXNoNo► Subscribe► Subscribe
Lannett
CLINDAMYCIN HYDROCHLORIDE
clindamycin hydrochloride
CAPSULE;ORAL065242-001Aug 12, 2005ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Formulary management
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot